MedTrace Logo

Ovarian Screening Study

NCT00267072 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2018-01-09

No results posted yet for this study

Summary

The objectives of this study are:

* To identify women at increased risk for developing ovarian cancer
* To detect ovarian cancers at an early stage
* To investigate the role of tumor membrane fragments as tumor markers for early ovarian carcinoma

Conditions

Sponsors & Collaborators

  • James Graham Brown Cancer Center

    collaborator OTHER

  • University of Louisville

    lead OTHER

Principal Investigators

  • Cyril W. Helm, MD · University of Louisville, James Graham Brown Cancer Center

Eligibility

Min Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-06-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00267072 on ClinicalTrials.gov